{"title": "Blood test could lead to cystic fibrosis treatment tailored to each patient", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Blood test could lead to cystic fibrosis treatment tailored to each patient"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/12/181212200803.htm"}], "link": "https://www.sciencedaily.com/releases/2018/12/181212200803.htm", "summary": "Researchers have used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient's precise biology.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Researchers have used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient's precise biology."}, "published": "Wed, 12 Dec 2018 20:08:03 EST", "published_parsed": [2018, 12, 13, 1, 8, 3, 3, 347, 0], "id": "https://www.sciencedaily.com/releases/2018/12/181212200803.htm", "guidislink": false}